Wave Background Image

Investor FAQs

Show All
Apogee is headquartered at 221 Crescent St., Building 17, Suite 102b, Waltham, MA 02453.
Apogee was founded and commenced operations in 2022.
Apogee’s initial public offering (IPO) occurred on July 13, 2023.
Apogee’s fiscal year ends on December 31st.
Apogee is traded on the Nasdaq Global Market under the ticker symbol APGE, and its CUSIP number is 03770N 101.
American Stock Transfer and Trust
59 Maiden Lane
New York NY 10038
Ernst & Young LLP
200 Clarendon Street
Boston, MA 02116
Gibson, Dunn & Crutcher LLP
555 Mission Street, Suite 3000
San Francisco, CA 94105
Apogee’s press release archives can be viewed here.
Apogee’s SEC filings can be viewed here.
You can submit queries to Apogee’s investor relations department by contacting investors@apogeetherapeutics.com.